LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Home・Listă Acțiuni・NeoGenomics Inc

NeoGenomics Inc

Închisă

11.3 -1.22

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

11.2

Maxim

11.81

Indicatori cheie
By Trading Economics
Venit	-7.2M -17M
Vânzări	-3.5M 187M
EPS	0.01
Marjă de profit	-9.164
Angajați	2,500
EBITDA	-5.8M -567K

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+30.51% upside

Dividende
By Dow Jones
Următoarele câștiguri	28 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	305M 1.4B
Deschiderea anterioară	12.52
Închiderea anterioară	11.3

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 iun. 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

9 iun. 2026, 20:09 UTC

Market Talk

Cryptocurrency Traders Look for Bitcoin Bottom -- Market Talk

9 iun. 2026, 16:34 UTC

Market Talk

Cryptocurrency Weakness Follows Selling in Equities -- Market Talk

9 iun. 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

9 iun. 2026, 14:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iun. 2026, 14:44 UTC

Market Talk

Short-Term BTC Holders Have Worst Week Since 2015 -- Market Talk

9 iun. 2026, 14:27 UTC

Market Talk

Outflows Slow But Don't Stop for Bitcoin ETFs -- Market Talk

9 iun. 2026, 13:46 UTC

Market Talk

Privacy Coins Extend Rebound While BTC Falls -- Market Talk

9 iun. 2026, 09:24 UTC

Market Talk

Bitcoin Needs Much Weaker Dollar to Stage Decent Recovery -- Market Talk

9 iun. 2026, 06:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

9 iun. 2026, 06:50 UTC

Market Talk

Bitcoin Falls Slightly as It Struggles to Recover From Recent Selloff -- Market Talk

8 iun. 2026, 17:29 UTC

Market Talk

Crypto Market Still Stays in 'Extreme Fear' Amid Rebound -- Market Talk

8 iun. 2026, 17:29 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 iun. 2026, 16:40 UTC

Market Talk

Cryptocurrencies Rise After Iran and Israel Halt Exchanges of Fire -- Market Talk

8 iun. 2026, 13:40 UTC

Market Talk

Crypto Shows Turnaround After Prolonged Losing Streak -- Market Talk

8 iun. 2026, 03:59 UTC

Market Talk

Bitcoin Rises as Investors Focus on Long-Term Demand Drivers -- Market Talk

5 iun. 2026, 18:34 UTC

Market Talk

Hyperliquid ETFs Have Inflows Despite Crypto Weakness -- Market Talk

5 iun. 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5 iun. 2026, 15:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 iun. 2026, 15:16 UTC

Market Talk

Zcash Tumbles After Exploit Found -- Market Talk

5 iun. 2026, 14:18 UTC

Market Talk

Bitcoin Breaks Streak of ETF Outflows -- Market Talk

5 iun. 2026, 13:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 iun. 2026, 13:42 UTC

Market Talk

Zcash Sheds 31% as Cryptocurrency Plummets -- Market Talk

5 iun. 2026, 07:12 UTC

Market Talk

Cryptocurrencies Fall Sharply as Selloff Continues -- Market Talk

4 iun. 2026, 17:09 UTC

Market Talk

Retest of $55k Seen Possible for Bitcoin -- Market Talk

4 iun. 2026, 16:46 UTC

Market Talk

Strategy BTC Sale Continues to Weigh on Prices -- Market Talk

4 iun. 2026, 09:20 UTC

Market Talk

Ether Stays Under Pressure, Underpeforming Bitcoin -- Market Talk

4 iun. 2026, 07:23 UTC

Market Talk

Bitcoin Remains Weak on Geopolitical Uncertainty, U.S. Rate-Rise Bets -- Market Talk

4 iun. 2026, 03:02 UTC

Market Talk

Bitcoin Slips Amid Risk-Off Sentiment -- Market Talk

3 iun. 2026, 18:24 UTC

Market Talk

New Bitcoin Support Level at $65k -- Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

30.51% sus

Prognoză pe 12 luni

Medie 14.93 USD 30.51%

Maxim 25 USD

Minim 11 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 10 analiști care au acordat evaluări ale acțiunilor NeoGenomics Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.